查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1482417

单细胞分析市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2032 年

Single-Cell Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 301 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究详细分析了单细胞分析市场，并提供了对其多方面动态和预期未来趋势的深入见解。这份综合报告涵盖了市场发展、驱动因素、障碍和新兴模式，并提供了 2024 年至 2032 年的关键统计数据和预测。

关键见解

  • 单细胞分析市场规模（2024 年）：57 亿美元
  • 预测市场规模（2032 年）：245.2 亿美元
  • 全球市场成长率（复合年增长率，2024-2032）：23.17%

单细胞分析市场 - 研究范围：

该市场由各种应用组成，这些应用对于增进我们对细胞异质性和疾病机制的理解至关重要。单细胞分析技术使研究人员能够在细胞层面剖析复杂的生物系统，深入瞭解细胞多样性、基因表现谱和生物标记识别。由于单细胞分析在癌症研究、免疫学、神经科学和干细胞生物学等各领域的应用不断扩大，该市场正在显着成长。此外，单细胞分析平台的技术进步和生命科学研究投资的增加正在推动市场扩张。

推动市场成长的因素：

推动单细胞分析市场成长的因素很多。对高解析度细胞分析工具的需求不断增长，以破解癌症和神经退化性疾病等疾病中的细胞异质性，这是一个关键驱动因素。此外，单细胞定序技术的进步，例如基于液滴的方法和空间转录组学，正在扩大单细胞分析应用的范围。此外，学术研究机构、製药公司和技术提供者之间的合作正在推动单细胞分析平台的创新并推动市场成长。

市场限制因素：

儘管单细胞分析市场前景广阔，仍面临一些课题。高设备成本和数据分析的复杂性是单细胞分析技术广泛采用的主要障碍，特别是在资源有限的环境中。此外，单细胞数据的解释和实验方案的标准化仍然是研究人员面临的重要课题。此外，对数据再现性的担忧以及对强有力的品质控制措施的需求也在一定程度上阻碍了市场的成长。

市场机会：

单细胞分析市场充满了创新和成长的机会。单细胞分离技术的进步，加上多组学方法的整合，有可能扩大单细胞分析在个人化医疗和药物发现的应用领域。此外，单细胞空间分析技术的出现为研究各种病理条件下的组织微环境和细胞间相互作用提供了新的途径。此外，技术开发商和製药公司之间的策略联盟开发新型单细胞分析方法和生物标记发现平台可能会推动市场扩张。

本报告解决的关键问题

  • 推动单细胞分析市场全球成长的关键因素是什么？
  • 技术进步如何影响单细胞分析技术的开发与采用？
  • 市场参与者面临的主要课题和机会是什么？
  • 哪些研究领域和治疗应用预计将出现最高成长？
  • 领先公司正在采取哪些策略来巩固其市场地位并满足研究人员和临床医生不断变化的需求？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
  • 情境预测
  • 机会图分析
  • 投资可行性矩阵
  • PESTLE 和 Porter 分析
  • 监理状况
  • 依地区划分的母公司市场前景

第四章全球单细胞分析市场分析

  • 过去的市场规模金额分析，2019-2023 年
  • 目前与未来的市场规模预测：2024-2032 年
    • 年成长趋势分析
    • 绝对数量机会分析

第五章全球单细胞分析市场分析：依产品

  • 简介/主要发现
  • 过去的市场规模货币分析：依产品分类，2019-2023 年
  • 2024-2032 年依产品划分的当前和未来市场规模货币分析和预测
    • 消耗品
    • 设备
  • 年成长趋势分析：依产品分类，2019-2023 年
  • 绝对价值机会分析：依产品分类，2024-2032 年

第六章全球单细胞分析市场分析：依应用

  • 简介/主要发现
  • 过去的市场规模金额分析：依应用划分，2019-2023 年
  • 当前和未来的市场规模货币分析和预测：依应用划分，2024 年至 2032 年
    • 癌症
    • 免疫学
    • 神经病学
    • 干细胞
    • 无创产前诊断
    • 体外受精
    • 其他
  • 年成长趋势分析：依应用分类，2019-2023 年
  • 绝对机会分析：依应用分类，2024-2032 年

第 7 章全球单细胞分析市场分析：依工作流程

  • 简介/主要发现
  • 过去的市场规模货币分析：依工作流程，2019-2023 年
  • 当前和未来的市场规模货币分析和预测：依工作流程划分，2024-2032 年
    • 单细胞分离/文库製备
    • 下游分析
    • 资料分析
  • 年成长趋势分析：依工作流程划分，2019-2023 年
  • 绝对价值机会分析：依工作流程划分，2024-2032 年

第 8 章全球单细胞分析市场分析：依最终使用者划分

  • 简介/主要发现
  • 过去的市场规模金额分析：以最终用户划分，2019-2023 年
  • 当前和未来的市场规模货币分析和预测：依最终用户划分，2024-2032 年
    • 学术/研究机构
    • 生技/製药公司
    • 医院/诊断实验室
    • 其他
  • 年成长趋势分析：依最终用户划分，2019-2023 年
  • 绝对价值机会分析：依最终使用者划分，2024-2032 年

第 9 章全球单细胞分析市场分析：依地区

  • 简介
  • 过去的市场规模分析：依地区划分，2019-2023 年
  • 当前市场规模货币分析与预测：依地区划分，2024-2032 年
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 市场吸引力分析：依地区划分

第 10 章北美单细胞分析市场分析：依国家

第 11 章依国家划分的拉丁美洲单细胞分析市场分析

第 12 章欧洲单细胞分析市场分析：依国家

第 13 章亚太地区单细胞分析市场国家分析

第 14 章中东和非洲单细胞分析市场分析：依国家

第十五章主要国家单细胞分析市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 中国
  • 日本
  • 韩国
  • 新加坡
  • 泰国
  • 印尼
  • 澳大利亚
  • 纽西兰
  • 海湾合作委员会国家
  • 南非
  • 以色列

第十六章市场结构分析

  • 竞争对手仪表板
  • 竞争基准
  • 主要公司市占率分析

第十七章竞争分析

  • 衝突详情
    • Thermo Fisher Scientific, Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Merck KGaA
    • Becton, Dickinson &Company
    • Fluidigm Corporation
    • 10x Genomics, Inc.
    • BGI
    • Novogene Corporation

第 18 章先决条件与使用的缩写

第十九章研究方法

简介目录
Product Code: PMRREP33180

Persistence Market Research provides an in-depth analysis of the Single-Cell Analysis Market, offering detailed insights into its multifaceted dynamics and projected future trends. This comprehensive report encompasses market developments, driving forces, hurdles, and emerging patterns, furnishing crucial statistics and forecasts from 2024 to 2032.

Key Insights:

  • Single-Cell Analysis Market Size (2024): USD 5.70 Billion
  • Projected Market Value (2032): USD 24.52 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 23.17%

Single-Cell Analysis Market - Report Scope:

The market comprises various applications crucial for advancing our understanding of cellular heterogeneity and disease mechanisms. Single-cell analysis technologies enable researchers to dissect complex biological systems at the cellular level, offering insights into cellular diversity, gene expression profiles, and biomarker identification. The market is witnessing substantial growth driven by the expanding applications of single-cell analysis in various fields such as cancer research, immunology, neuroscience, and stem cell biology. Additionally, technological advancements in single-cell analysis platforms, coupled with increasing investments in life sciences research, are propelling market expansion.

Market Growth Drivers:

A multitude of factors propel the growth of the Single-Cell Analysis Market. The rising demand for high-resolution cellular analysis tools to decipher cellular heterogeneity in diseases like cancer and neurodegenerative disorders is a significant driver. Moreover, advancements in single-cell sequencing technologies, such as droplet-based methods and spatial transcriptomics, are expanding the scope of single-cell analysis applications. Furthermore, collaborations between academic research institutions, pharmaceutical companies, and technology providers are fostering innovation in single-cell analysis platforms, thereby driving market growth.

Market Restraints:

Despite its promising prospects, the Single-Cell Analysis Market faces certain challenges. High instrument costs and complexity in data analysis pose significant barriers to the widespread adoption of single-cell analysis technologies, particularly in resource-constrained settings. Moreover, the interpretation of single-cell data and standardization of experimental protocols remain key challenges for researchers. Additionally, concerns regarding data reproducibility and the need for robust quality control measures hinder market growth to some extent.

Market Opportunities:

The Single-Cell Analysis Market presents ample opportunities for innovation and growth. Advancements in single-cell isolation techniques, coupled with the integration of multi-omics approaches, hold promise for expanding the application spectrum of single-cell analysis in personalized medicine and drug discovery. Furthermore, the emergence of single-cell spatial profiling technologies offers new avenues for studying tissue microenvironments and cell-cell interactions in various pathological conditions. Moreover, strategic collaborations between technology developers and pharmaceutical companies to develop novel single-cell analysis assays and biomarker discovery platforms are likely to fuel market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Single-Cell Analysis Market globally?
  • How are technological advancements influencing the development and adoption of single-cell analysis technologies?
  • What are the major challenges and opportunities for market participants?
  • Which research areas and therapeutic applications offer the highest growth potential?
  • What strategies are leading companies employing to strengthen their market position and address the evolving needs of researchers and clinicians?

Competitive Intelligence and Business Strategy:

Key players in the global Single-Cell Analysis Market, including biotechnology companies, instrument manufacturers, and academic research institutions, focus on innovation, product differentiation, and strategic collaborations to maintain their competitive edge. Companies invest in developing cutting-edge single-cell analysis platforms that offer high sensitivity, throughput, and multiplexing capabilities. Additionally, emphasis on user-friendly software solutions for data analysis and visualization enhances the usability of single-cell analysis platforms, driving their adoption among researchers. Strategic partnerships with academic research centers and pharmaceutical companies facilitate technology validation and accelerate the translation of single-cell analysis findings into clinical applications.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck KGaA
  • Becton, Dickinson & Company
  • Fluidigm Corporation
  • 10x Genomics Inc.
  • BGI
  • Novogene Corporation

Single-Cell Analysis Market Research Segmentation:

By Consumables

  • Consumables

Reagents

Assay Kits

  • Instruments
  • Manual Instruments

Microscopes

Hemocytometers

Automated Instruments

Flow Cytometers

Next Generation Sequencing

PCR Systems

High-content Screening System

Cell Microarrays

Automated Cell Counters

By Application Type

  • Cancer
  • Immunology
  • Neurology
  • Stem Cell
  • Non-invasive Prenatal Diagnosis
  • In-vitro Fertilization
  • Others

By Workflow

  • Single Cell Isolation & Library Preparation
  • Downstream Analysis
  • Data Analysis

By End User

  • Academic & Research Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostic Laboratories
  • Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Consumables
      • 5.3.1.1. Reagents
      • 5.3.1.2. Assay Kits
    • 5.3.2. Instruments
      • 5.3.2.1. Manual Instruments
      • 5.3.2.2. Microscopes
      • 5.3.2.3. Hemocytometers
      • 5.3.2.4. Automated Instruments
      • 5.3.2.5. Flow Cytometers
      • 5.3.2.6. Next Generation Sequencing
      • 5.3.2.7. PCR Systems
      • 5.3.2.8. High-content Screening System
      • 5.3.2.9. Cell Microarrays
      • 5.3.2.10. Automated Cell Counters
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 6.3.1. Cancer
    • 6.3.2. Immunology
    • 6.3.3. Neurology
    • 6.3.4. Stem Cell
    • 6.3.5. Non-invasive Prenatal Diagnosis
    • 6.3.6. In-vitro Fertilization
    • 6.3.7. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2032

7. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Workflow

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Workflow , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow , 2024-2032
    • 7.3.1. Single Cell Isolation & Library Preparation
    • 7.3.2. Downstream Analysis
    • 7.3.3. Data Analysis
  • 7.4. Y-o-Y Growth Trend Analysis By Workflow , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Workflow , 2024-2032

8. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By End-user

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2024-2032
    • 8.3.1. Academic & Research Laboratories
    • 8.3.2. Biotechnology & Pharmaceutical Companies
    • 8.3.3. Hospitals & Diagnostic Laboratories
    • 8.3.4. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End-user, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End-user, 2024-2032

9. Global Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Workflow
    • 10.2.5. By End-user
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Application
    • 10.3.4. By Workflow
    • 10.3.5. By End-user
  • 10.4. Key Takeaways

11. Latin America Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Workflow
    • 11.2.5. By End-user
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Application
    • 11.3.4. By Workflow
    • 11.3.5. By End-user
  • 11.4. Key Takeaways

12. Europe Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Workflow
    • 12.2.5. By End-user
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Workflow
    • 12.3.5. By End-user
  • 12.4. Key Takeaways

13. Asia Pacific Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. Singapore
      • 13.2.1.5. Thailand
      • 13.2.1.6. Indonesia
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of Asia Pacific
    • 13.2.2. By Product
    • 13.2.3. By Application
    • 13.2.4. By Workflow
    • 13.2.5. By End-user
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Workflow
    • 13.3.5. By End-user
  • 13.4. Key Takeaways

14. MEA Single-Cell Analysis Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Application
    • 14.2.4. By Workflow
    • 14.2.5. By End-user
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Workflow
    • 14.3.5. By End-user
  • 14.4. Key Takeaways

15. Key Countries Single-Cell Analysis Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Application
      • 15.1.2.3. By Workflow
      • 15.1.2.4. By End-user
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Application
      • 15.2.2.3. By Workflow
      • 15.2.2.4. By End-user
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Application
      • 15.3.2.3. By Workflow
      • 15.3.2.4. By End-user
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Application
      • 15.4.2.3. By Workflow
      • 15.4.2.4. By End-user
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Application
      • 15.5.2.3. By Workflow
      • 15.5.2.4. By End-user
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Application
      • 15.6.2.3. By Workflow
      • 15.6.2.4. By End-user
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Application
      • 15.7.2.3. By Workflow
      • 15.7.2.4. By End-user
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Application
      • 15.8.2.3. By Workflow
      • 15.8.2.4. By End-user
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Application
      • 15.9.2.3. By Workflow
      • 15.9.2.4. By End-user
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Application
      • 15.10.2.3. By Workflow
      • 15.10.2.4. By End-user
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Application
      • 15.11.2.3. By Workflow
      • 15.11.2.4. By End-user
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Application
      • 15.12.2.3. By Workflow
      • 15.12.2.4. By End-user
  • 15.13. Singapore
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Application
      • 15.13.2.3. By Workflow
      • 15.13.2.4. By End-user
  • 15.14. Thailand
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Application
      • 15.14.2.3. By Workflow
      • 15.14.2.4. By End-user
  • 15.15. Indonesia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Application
      • 15.15.2.3. By Workflow
      • 15.15.2.4. By End-user
  • 15.16. Australia
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Application
      • 15.16.2.3. By Workflow
      • 15.16.2.4. By End-user
  • 15.17. New Zealand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Application
      • 15.17.2.3. By Workflow
      • 15.17.2.4. By End-user
  • 15.18. GCC Countries
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Application
      • 15.18.2.3. By Workflow
      • 15.18.2.4. By End-user
  • 15.19. South Africa
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Application
      • 15.19.2.3. By Workflow
      • 15.19.2.4. By End-user
  • 15.20. Israel
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product
      • 15.20.2.2. By Application
      • 15.20.2.3. By Workflow
      • 15.20.2.4. By End-user

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Workflow
    • 16.3.5. By End-user

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. Thermo Fisher Scientific, Inc.
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. QIAGEN NV
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. Bio-Rad Laboratories Inc.
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Illumina Inc.
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. Merck KGaA
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Becton, Dickinson & Company
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Fluidigm Corporation
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. 10x Genomics, Inc.
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. BGI
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Novogene Corporation
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology